Literature DB >> 21255070

The activity of bacteriocins from Carnobacterium maltaromaticum UAL307 against gram-negative bacteria in combination with EDTA treatment.

Leah A Martin-Visscher1, Sabesan Yoganathan, Clarissa S Sit, Christopher T Lohans, John C Vederas.   

Abstract

Bacteriocins from gram-positive bacteria are potent antimicrobial peptides that inhibit pathogenic and food-spoilage bacteria. They are usually ineffective against gram-negative bacteria because they cannot penetrate the outer membrane (OM). Disruption of the OM of some gram-negative bacteria was reported to sensitize them to certain bacteriocins. This study evaluates the activity of three purified bacteriocins [carnocyclin A (CclA), carnobacteriocin BM1 (CbnBM1) and piscicolin 126 (PisA)] produced by Carnobacterium maltaromaticum UAL307, which has been approved for preservation of food in United States and Canada, against three gram-negative bacteria (Escherichia coli DH5α, Pseudomonas aeruginosa ATCC 14207 and Salmonella Typhimurium ATCC 23564). Their efficacy is compared with bacteriocins of other classes: the lantibiotics nisin A (positive control) and gallidermin, and the cyclic peptide subtilosin A (SubA). In combination with EDTA, CclA inhibited both E. coli and Pseudomonas. PisA inhibited Pseudomonas, but CbnBM1 showed weak activity toward Pseudomonas. In comparison, nisin and gallidermin inhibited the growth of all three strains, whereas SubA was active against E. coli and Pseudomonas only at high concentrations. The results reveal that UAL307 bacteriocins can inhibit gram-negative bacteria if the OM is weakened, and that the different classes of bacteriocins in this study exert unique modes of action toward such bacteria.
© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21255070     DOI: 10.1111/j.1574-6968.2011.02223.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  19 in total

Review 1.  Strategies for the use of bacteriocins in Gram-negative bacteria: relevance in food microbiology.

Authors:  Cláudia Vieira Prudêncio; Miriam Teresinha Dos Santos; Maria Cristina Dantas Vanetti
Journal:  J Food Sci Technol       Date:  2015-02-11       Impact factor: 2.701

Review 2.  Circular bacteriocins: biosynthesis and mode of action.

Authors:  Christina Gabrielsen; Dag A Brede; Ingolf F Nes; Dzung B Diep
Journal:  Appl Environ Microbiol       Date:  2014-08-29       Impact factor: 4.792

3.  Probiotics and antimicrobial peptides: the creatures' and substances' future in the twenty-first century: an opinion letter.

Authors:  Michael L Chikindas
Journal:  Probiotics Antimicrob Proteins       Date:  2014-06       Impact factor: 4.609

4.  The ABC Transporter CclEFGH Facilitates the Production of the Circular Bacteriocin Carnocyclin A.

Authors:  Marco J van Belkum; John C Vederas
Journal:  Probiotics Antimicrob Proteins       Date:  2012-12       Impact factor: 4.609

5.  Inhibitory effect of plantaricin peptides (Pln E/F and J/K) against Escherichia coli.

Authors:  Gargi Pal; Sheela Srivastava
Journal:  World J Microbiol Biotechnol       Date:  2014-08-20       Impact factor: 3.312

Review 6.  Bacteriocins from lactic acid bacteria and their potential clinical applications.

Authors:  Abigail Fernandes; Renitta Jobby
Journal:  Appl Biochem Biotechnol       Date:  2022-03-15       Impact factor: 3.094

Review 7.  Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature.

Authors:  Paul G Arnison; Mervyn J Bibb; Gabriele Bierbaum; Albert A Bowers; Tim S Bugni; Grzegorz Bulaj; Julio A Camarero; Dominic J Campopiano; Gregory L Challis; Jon Clardy; Paul D Cotter; David J Craik; Michael Dawson; Elke Dittmann; Stefano Donadio; Pieter C Dorrestein; Karl-Dieter Entian; Michael A Fischbach; John S Garavelli; Ulf Göransson; Christian W Gruber; Daniel H Haft; Thomas K Hemscheidt; Christian Hertweck; Colin Hill; Alexander R Horswill; Marcel Jaspars; Wendy L Kelly; Judith P Klinman; Oscar P Kuipers; A James Link; Wen Liu; Mohamed A Marahiel; Douglas A Mitchell; Gert N Moll; Bradley S Moore; Rolf Müller; Satish K Nair; Ingolf F Nes; Gillian E Norris; Baldomero M Olivera; Hiroyasu Onaka; Mark L Patchett; Joern Piel; Martin J T Reaney; Sylvie Rebuffat; R Paul Ross; Hans-Georg Sahl; Eric W Schmidt; Michael E Selsted; Konstantin Severinov; Ben Shen; Kaarina Sivonen; Leif Smith; Torsten Stein; Roderich D Süssmuth; John R Tagg; Gong-Li Tang; Andrew W Truman; John C Vederas; Christopher T Walsh; Jonathan D Walton; Silke C Wenzel; Joanne M Willey; Wilfred A van der Donk
Journal:  Nat Prod Rep       Date:  2013-01       Impact factor: 13.423

8.  Diversity and Antimicrobial Activity towards Listeria spp. and Escherichia coli among Lactic Acid Bacteria Isolated from Ready-to-Eat Seafood.

Authors:  Jelena Stupar; Ingunn Grimsbo Holøymoen; Sunniva Hoel; Jørgen Lerfall; Turid Rustad; Anita Nordeng Jakobsen
Journal:  Foods       Date:  2021-01-29

9.  Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota.

Authors:  Eliette Riboulet-Bisson; Mark H J Sturme; Ian B Jeffery; Michelle M O'Donnell; B Anne Neville; Brian M Forde; Marcus J Claesson; Hugh Harris; Gillian E Gardiner; Patrick G Casey; Peadar G Lawlor; Paul W O'Toole; R Paul Ross
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

Review 10.  Novel formulations for antimicrobial peptides.

Authors:  Ana Maria Carmona-Ribeiro; Letícia Dias de Melo Carrasco
Journal:  Int J Mol Sci       Date:  2014-10-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.